Epitalon vs. Epithalon: Spelling, Structure & Telomere Research

Epitalon vs. Epithalon: Spelling, Structure & Telomere Research

> Research Disclaimer: This article is intended for laboratory and educational reference only. Epitalon/Epithalon is a research compound not approved for human therapeutic use. All content is for scientific purposes only and does not constitute medical advice.

The Spelling Question: Epitalon or Epithalon?

Researchers frequently encounter both spellings — Epitalon and Epithalon — in the scientific literature. Both refer to the identical synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (alanyl-glutamyl-aspartyl-glycine). The discrepancy arises from transliteration differences between Russian scientific literature (where the compound was originally developed as "Эпиталон") and English-language publications. For the purposes of this article, both terms are used interchangeably.

Background and Discovery

Epitalon was developed by the St. Petersburg Institute of Bioregulation and Gerontology under the direction of Professor Vladimir Khavinson, who has published extensively on short regulatory peptides and their role in aging. The compound was derived from a natural peptide extract of the pineal gland called epithalamin, and was subsequently synthesized as a shorter, more stable tetrapeptide for research purposes.

The primary research interest in Epitalon centers on its reported ability to activate telomerase — the enzyme responsible for maintaining telomere length at the ends of chromosomes. Telomere shortening is considered a hallmark of cellular aging, and compounds that modulate telomerase activity have attracted significant scientific attention.

Molecular Structure

| Property | Value | |---|---| | Sequence | Ala-Glu-Asp-Gly | | Molecular Formula | C14H22N4O9 | | Molecular Weight | 390.34 g/mol | | CAS Number | 307297-39-8 | | Peptide Length | 4 amino acids (tetrapeptide) | | Solubility | Water-soluble |

Telomere Biology: Why Telomere Length Matters

Telomeres are repetitive DNA sequences (TTAGGG in humans) that cap the ends of chromosomes, protecting them from degradation and end-to-end fusion. With each cell division, telomeres shorten due to the "end-replication problem" — a fundamental limitation of DNA polymerase. When telomeres reach a critically short length, cells enter a state of replicative senescence (permanent cell cycle arrest) or undergo apoptosis.

Telomerase, a ribonucleoprotein complex, counteracts this process by adding telomeric repeats to chromosome ends. In most somatic cells, telomerase activity is low or absent, contributing to progressive telomere attrition. Germ cells, stem cells, and certain immune cells maintain higher telomerase activity.

Preclinical Research on Epitalon

The majority of published research on Epitalon comes from Russian-language journals and the work of Khavinson's group. Key findings from preclinical studies include:

Telomerase Activation in Human Somatic Cells

A study published in Bulletin of Experimental Biology and Medicine reported that Epitalon treatment of cultured human fetal fibroblasts increased telomerase activity and extended the replicative lifespan of cells compared to untreated controls [1]. The researchers observed that treated cells underwent more population doublings before reaching senescence.

Telomere Elongation in Aged Organisms

Research in aged rats demonstrated that Epitalon administration was associated with measurable increases in telomere length in peripheral blood lymphocytes [2]. The authors proposed that this effect was mediated through upregulation of telomerase reverse transcriptase (TERT) expression.

Lifespan Studies in Model Organisms

Multiple studies in Drosophila melanogaster and rodent models have reported modest but statistically significant increases in mean and maximum lifespan following Epitalon treatment [3]. In one frequently cited study, female rats treated with Epitalon showed a 13% increase in mean lifespan compared to controls, along with reduced incidence of spontaneous tumors.

Melatonin Synthesis and Circadian Regulation

Epitalon has also been studied for its effects on pineal gland function. Research suggests it may stimulate melatonin synthesis and restore age-related declines in pineal activity, which could have downstream effects on circadian rhythm regulation and antioxidant defense [4].

Comparison with Other Telomere-Targeting Research Compounds

| Compound | Mechanism | Research Stage | |---|---|---| | Epitalon | Telomerase activation (TERT upregulation) | Preclinical / early human observational | | TA-65 (Cycloastragenol) | Telomerase activation | Phase I human trials | | GDF11 | Systemic rejuvenation factor | Preclinical | | NAD+ precursors (NMN, NR) | Sirtuin activation, DNA repair | Phase I/II human trials | | Rapamycin | mTOR inhibition, senolytic | Phase I/II human trials |

Stability and Reconstitution

Epitalon is a hydrophilic tetrapeptide that dissolves readily in sterile water or bacteriostatic water. For research purposes, lyophilized Epitalon should be stored at -20°C and protected from light. Reconstituted solutions should be kept at 4°C and used within 28 days.

Current Research Landscape

While the preclinical data on Epitalon is intriguing, the research base is limited by several factors: most studies originate from a single research group, many are published in Russian-language journals with limited independent replication, and no large-scale randomized controlled trials in humans have been published. Independent replication of the telomerase activation findings would significantly strengthen the evidence base.

Conclusion

Epitalon (Epithalon) is a synthetic tetrapeptide derived from the pineal peptide epithalamin, developed by Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. Preclinical research suggests it may activate telomerase and extend cellular replicative lifespan in vitro, with some animal studies reporting modest lifespan extension. The compound represents an interesting research target in the field of biogerontology, though independent replication and rigorous human clinical data remain limited.

References

[1] Khavinson VKh, et al. "Epitalon peptide induces telomerase activity and telomere elongation in human somatic cells." Bull Exp Biol Med. 2003;135(6):590-592. https://pubmed.ncbi.nlm.nih.gov/12937682/

[2] Khavinson V, et al. "Peptide regulation of aging." Adv Gerontol. 2005;17:11-18. https://pubmed.ncbi.nlm.nih.gov/16075718/

[3] Anisimov VN, et al. "Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice." Biogerontology. 2003;4(4):193-202. https://pubmed.ncbi.nlm.nih.gov/14501183/

[4] Kossoy G, et al. "Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice." In Vivo. 2006;20(2):253-257. https://pubmed.ncbi.nlm.nih.gov/16634527/